HPV-related anogenital disease and HIV infection: not always 'ordinary' condylomata acuminata

被引:0
|
作者
Mudrikova, T. [1 ]
Jaspers, C. [1 ]
Ellerbroek, R. [1 ]
Hoepelman, A. [1 ]
机构
[1] Univ Med Ctr Utrecht, Dept Internal Med & Infect Dis, NL-3584 CX Utrecht, Netherlands
来源
NETHERLANDS JOURNAL OF MEDICINE | 2008年 / 66卷 / 03期
关键词
Buschke-Loewenstein tumour; HIV; human papillomavirus;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Human papillomavirus (HPV) is responsible for various diseases in the anogenital region which range from benign condylomata acuminata to anal carcinoma. Buschke-Loewenstein tumour is a clinically 'intermediate' condition which is histologically benign but due to extensive destruction of the local tissues can show malignant behaviour. Its early recognition as a different clinical entity to 'ordinary' condylomata acuminata. is important for its adequate management. Immunocompromised persons, such as those with HIV infection, have a higher incidence of HPV-related anogenital disease. Different aspects of the HPV-related anogenital disease in HIV-positive individuals are discussed.
引用
收藏
页码:98 / 102
页数:5
相关论文
共 50 条
  • [41] Men's beliefs about HPV-related disease
    Brewer, Noel T.
    Ng, Terence W.
    McRee, Annie-Laurie
    Reiter, Paul L.
    JOURNAL OF BEHAVIORAL MEDICINE, 2010, 33 (04) : 274 - 281
  • [42] Update on Vaccination Clinical Trials for HPV-Related Disease
    Erickson, Britt K.
    Landers, Emily E.
    Huh, Warner K.
    CLINICAL THERAPEUTICS, 2014, 36 (01) : 8 - 16
  • [43] The impact of HIV antiviral therapy on human papillomavirus (HPV) infections and HPV-related diseases
    Heard, I
    Palefsky, JM
    Kazatchkine, MD
    ANTIVIRAL THERAPY, 2004, 9 (01) : 13 - 22
  • [44] Prevention and control of HPV infection and HPV-related cancers in Colombia- a meeting report
    Vorsters A.
    Bosch F.X.
    Bonanni P.
    Franco E.L.
    Baay M.
    Simas C.
    Waheed D.-E.-N.
    Castro C.
    Murillo R.
    Trujillo L.
    Wiesner C.
    Muñoz N.
    BMC Proceedings, 14 (Suppl 9)
  • [45] Vermeidung und Therapie HPV-assoziierter Erkrankungen durch VakzinationsprogrammeVaccination programs for the prevention and therapy of HPV-related anogenital diseases
    M. Hampl
    Der Gynäkologe, 2006, 39 (2): : 122 - 133
  • [46] Natural history of anogenital HPV infection and related disease among HIV-positive men: Findings from a Cohort Study in South Africa
    Chikandiwa, A.
    Pisa, P. T.
    Tamalet, C.
    Muller, E. E.
    Kularatne, R.
    Michelow, P.
    Chersich, M. F.
    Mayaud, P.
    Delany-Moretlwe, S.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21 : 35 - 35
  • [47] ORAL HPV-RELATED MALIGNANCES IN HIV POSITIVE INDIVIDUALS: A CLINICAL CASE
    Vignale, F.
    Ucciferri, C.
    Falasca, K.
    Mancino, P.
    Vannucci, M.
    Pizzigallo, E.
    Vecchiet, J.
    INFECTION, 2011, 39 : S82 - S82
  • [48] Current and future direction in treatment of HPV-related cervical disease
    Khairkhah, Niloofar
    Bolhassani, Azam
    Najafipour, Reza
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2022, 100 (06): : 829 - 845
  • [49] INCIDENCE OF ANAL HPV AND HPV-RELATED SEQUELAE IN HIV-INFECTED AND UNINFECTED US ADOLESCENTS
    Mullins, T.
    Wilson, C.
    Rudy, B.
    Sucharew, H.
    Kahn, J.
    SEXUALLY TRANSMITTED INFECTIONS, 2011, 87 : A120 - A120
  • [50] Clinical management of HPV-related disease of the lower genital tract
    Kyrgiou, M.
    Valasoulis, G.
    Founta, C.
    Koliopoulos, G.
    Karakitsos, P.
    Nasioutziki, M.
    Navrozoglou, I.
    Dalkalitsis, N.
    Paraskevaidis, E.
    WOMEN'S HEALTH AND DISEASE, 2010, 1205 : 57 - 68